VYOME HOLDINGS, INC. Income Taxes Paid
VYOME HOLDINGS, INC. (HIND) reported Income Taxes Paid of $0 for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-12.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaid · last filed 2021-05-12
- VYOME HOLDINGS, INC. income taxes paid for the quarter ending 2021-03-31 was $0.00.
- VYOME HOLDINGS, INC. income taxes paid for the quarter ending 2020-03-31 was $0.00.
- VYOME HOLDINGS, INC. income taxes paid for fiscal 2020 was $0.00.
- VYOME HOLDINGS, INC. income taxes paid for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- VYOME HOLDINGS, INC. income taxes paid for fiscal 2018 was $7.00K, a 250.00% increase from fiscal 2017.
- VYOME HOLDINGS, INC. income taxes paid for fiscal 2017 was $2.00K.
| Period end | Income Taxes Paid 3 month | Income Taxes Paid 12 month |
|---|---|---|
| 2021-03-31 | $0.00 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $0.00 10-K · filed 2021-03-12 | |
| 2020-03-31 | $0.00 10-Q · filed 2021-05-12 | |
| 2019-12-31 | $0.00 10-K · filed 2021-03-12 | |
| 2018-12-31 | $7.00K 10-K · filed 2020-02-27 | |
| 2017-12-31 | $2.00K 10-K · filed 2019-02-22 | |
| 2016-12-31 | $0.00 10-K · filed 2018-03-05 | |
| 2015-12-31 | $2.00K 10-K · filed 2018-03-05 | |
| 2014-12-31 | $1.00K 10-K · filed 2017-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |